Morgan Stanley’s IB Acquisition Corp IBAC Stock Holding History

Morgan Stanley’s Portfolio IBAC Stock Details IBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$544	Sell	51 -11	-18%	-$117	﹤0.01%	7602
2025 Q4	$651	Buy	62 +42	+210%	+$439	﹤0.01%	7455
2025 Q3	$210	Sell	20 -44	-69%	-$463	﹤0.01%	7594
2025 Q2	$668	Buy	64 +48	+300%	+$499	﹤0.01%	7383
2025 Q1	$165	Buy	+16	New	+$164	﹤0.01%	7493

Other funds holding IBAC

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley's IBAC Position: Q1 2026 in Review

Morgan Stanley reduced its IB Acquisition Corp (IBAC) stake by 18% in Q1 2026, selling an estimated $117 and leaving 51 shares worth $544. The position accounts for ﹤0.01% of the portfolio, ranked #7602.

Morgan Stanley first reported a position in IBAC in Q1 2025 and has held it in 5 quarters since. The position peaked at $668 in Q2 2025. 6 funds tracked by Wall St. Rank hold IBAC as of Q1 2026.

Morgan Stanley held 51 shares of IB Acquisition Corp worth $544 as of Q1 2026.
Morgan Stanley sold 11 IB Acquisition Corp shares in Q1 2026, an estimated $117.
IB Acquisition Corp made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7602 holding.
Morgan Stanley first reported a position in IB Acquisition Corp in Q1 2025 and has held it in 5 quarters since.
Morgan Stanley's IB Acquisition Corp position peaked at $668 in Q2 2025.
6 funds tracked by Wall St. Rank held IB Acquisition Corp as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.